Well if there isn't some price action soon to take into account the FDA de-risking, this company will be taken out sooner, rather than later. I was thinking competitors will wait for AXP to spend their own $$ marketing it and establishing the market presence before they take out, but this MC seems like a no brainer to lob an offer on the table.
I just can't help to think the announcement yesterday about the new 510k has confused the market on its approval status.
Well if there isn't some price action soon to take into account...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $4.303K | 2.151M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 40085905 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 91807222 | 63 |
View Market Depth
| Last trade - 10.57am 04/12/2024 (20 minute delay) ? |
| AXP (ASX) Chart |
